insights_auto
Why is ALNOV down 3,30%?
Dive Deeperchevron_right
ALNOV:EPA
Novacyt SA
0,43 €
arrow_downward
-3,30%(-0,014) 1D
20 қар., 17:35:10 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
0,43 €
High
0,44 €
Low
0,42 €
Mkt. cap
28,77 млн
Avg. vol.
128,00 м.
Volume
64,11 мың
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,37 €
Shares outstanding
72,59 млн
No. of employees
228
Open
0,43 €
High
0,44 €
Low
0,42 €
Mkt. cap
28,77 млн
Avg. vol.
128,00 м.
Volume
64,11 мың
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,37 €
Shares outstanding
72,59 млн
No. of employees
228
News stories
From web sources and news partners
WHEC.com
·
11 минут бұрын
S&P 500 sinks 3.7% and the Nasdaq composite goes negative for the year as rout in tech stocks tanks the market
WSJ
·
11 сағат бұрын
S&P 500 Flirts With Correction
Los Angeles Times
·
3 сағат бұрын
S&P 500 falls 10% from record, entering correction as AI trade unravels
The Motley Fool
·
11 сағат бұрын
Bitcoin Is 35% Below Its 52-Week High While the S&P 500 Is Up. Here’s What That Says About the Digital Gold Thesis.
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees228
Founded2006 ж. 03 шіл.
Headquarters-
SectorHealth Care
Industry-
Websitenovacyt.com